Hi Alan
Issue is more about the strength of the evidence base on effectiveness of some interventions – this is needed for any cost effectiveness analysis – which still can be problematic when this evidence from very different country contexts. Context plays big role in implementation of many public health actions and needs to be factored into econ eval as well
BW
David
From: Anglo-American Health Policy Network [mailto:[log in to unmask]] On Behalf Of Alan Maynard
Sent: 16 March 2012 15:38
To: [log in to unmask]
Subject: Re: JHPPL
Thanks Adam
Still think a pertinent issue is that pub. health/prevention evaluation methods weak especially in relation to the neglect of economic evaluation.NICE pub. health efforts stymied by lack of cost effectiveness data
This field just like daft PCORI in the USA=effectiveenss analysis with consideration of costs is like a coach with no horses! As ever " what is clinically effective may not be cost effective but what is cost effective is always clinically effective"
Blessings to all!
Alan
On 16 March 2012 11:55, Adam Oliver <[log in to unmask]> wrote:
Hi
The latest issue of JHPPL, which is a themed issue of prevention
politics and public health governance, is on-line, and can be viewed
at: http://jhppl.dukejournals.org/content/current
Best,
Adam
Please access the attached hyperlink for an important electronic communications disclaimer: http://lse.ac.uk/emailDisclaimer